

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | gamma-aminobutyric acid transport (GO:0015812) | 5.16991641 |
| 2 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.02726977 |
| 3 | behavioral response to nicotine (GO:0035095) | 4.51725846 |
| 4 | presynaptic membrane assembly (GO:0097105) | 4.42677955 |
| 5 | nucleobase catabolic process (GO:0046113) | 4.16823103 |
| 6 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.06808253 |
| 7 | proline transport (GO:0015824) | 3.95174678 |
| 8 | presynaptic membrane organization (GO:0097090) | 3.94274577 |
| 9 | transmission of nerve impulse (GO:0019226) | 3.77209535 |
| 10 | protein-cofactor linkage (GO:0018065) | 3.73965299 |
| 11 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.73285441 |
| 12 | postsynaptic membrane organization (GO:0001941) | 3.67128841 |
| 13 | neuron cell-cell adhesion (GO:0007158) | 3.63302978 |
| 14 | negative regulation of telomere maintenance (GO:0032205) | 3.62844280 |
| 15 | L-fucose catabolic process (GO:0042355) | 3.62194861 |
| 16 | fucose catabolic process (GO:0019317) | 3.62194861 |
| 17 | L-fucose metabolic process (GO:0042354) | 3.62194861 |
| 18 | vocalization behavior (GO:0071625) | 3.55735726 |
| 19 | regulation of action potential (GO:0098900) | 3.50016963 |
| 20 | negative regulation of multicellular organism growth (GO:0040015) | 3.45629155 |
| 21 | nonmotile primary cilium assembly (GO:0035058) | 3.45522415 |
| 22 | protein polyglutamylation (GO:0018095) | 3.41236499 |
| 23 | kynurenine metabolic process (GO:0070189) | 3.25520746 |
| 24 | axoneme assembly (GO:0035082) | 3.25150910 |
| 25 | regulation of memory T cell differentiation (GO:0043380) | 3.23330991 |
| 26 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.22354637 |
| 27 | regulation of collateral sprouting (GO:0048670) | 3.21249748 |
| 28 | synaptic transmission, cholinergic (GO:0007271) | 3.17996763 |
| 29 | regulation of development, heterochronic (GO:0040034) | 3.12257870 |
| 30 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.11638607 |
| 31 | regulation of timing of cell differentiation (GO:0048505) | 3.11197081 |
| 32 | response to pheromone (GO:0019236) | 3.08460299 |
| 33 | establishment of mitochondrion localization (GO:0051654) | 3.07263797 |
| 34 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.04517959 |
| 35 | protein localization to synapse (GO:0035418) | 3.04292509 |
| 36 | regulation of telomere maintenance (GO:0032204) | 3.03691134 |
| 37 | startle response (GO:0001964) | 3.02302254 |
| 38 | epithelial cilium movement (GO:0003351) | 3.02288471 |
| 39 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.02073992 |
| 40 | indole-containing compound catabolic process (GO:0042436) | 2.99971091 |
| 41 | indolalkylamine catabolic process (GO:0046218) | 2.99971091 |
| 42 | tryptophan catabolic process (GO:0006569) | 2.99971091 |
| 43 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.98422440 |
| 44 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.93599664 |
| 45 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.92915172 |
| 46 | neuronal action potential propagation (GO:0019227) | 2.90443713 |
| 47 | sex differentiation (GO:0007548) | 2.86546679 |
| 48 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.85967121 |
| 49 | detection of light stimulus involved in visual perception (GO:0050908) | 2.85967121 |
| 50 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.77977817 |
| 51 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.76299734 |
| 52 | glutamate receptor signaling pathway (GO:0007215) | 2.75891560 |
| 53 | synapse assembly (GO:0007416) | 2.75848932 |
| 54 | synaptic vesicle maturation (GO:0016188) | 2.74968741 |
| 55 | protein localization to cilium (GO:0061512) | 2.74614380 |
| 56 | neuronal action potential (GO:0019228) | 2.72095836 |
| 57 | tryptophan metabolic process (GO:0006568) | 2.71588275 |
| 58 | indolalkylamine metabolic process (GO:0006586) | 2.71323784 |
| 59 | synaptic transmission, glutamatergic (GO:0035249) | 2.69413083 |
| 60 | behavioral response to ethanol (GO:0048149) | 2.67995990 |
| 61 | retinal cone cell development (GO:0046549) | 2.67636736 |
| 62 | cellular ketone body metabolic process (GO:0046950) | 2.66117064 |
| 63 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.65774938 |
| 64 | adult walking behavior (GO:0007628) | 2.64105141 |
| 65 | inner ear receptor stereocilium organization (GO:0060122) | 2.61493627 |
| 66 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.61086869 |
| 67 | olfactory bulb development (GO:0021772) | 2.59439897 |
| 68 | C4-dicarboxylate transport (GO:0015740) | 2.59121845 |
| 69 | cilium movement (GO:0003341) | 2.58644406 |
| 70 | photoreceptor cell maintenance (GO:0045494) | 2.54849226 |
| 71 | intraciliary transport (GO:0042073) | 2.54830306 |
| 72 | ubiquinone metabolic process (GO:0006743) | 2.53841237 |
| 73 | cilium morphogenesis (GO:0060271) | 2.52159015 |
| 74 | reflex (GO:0060004) | 2.51928630 |
| 75 | cellular biogenic amine catabolic process (GO:0042402) | 2.50834293 |
| 76 | amine catabolic process (GO:0009310) | 2.50834293 |
| 77 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.50577797 |
| 78 | seminiferous tubule development (GO:0072520) | 2.50533855 |
| 79 | regulation of cilium movement (GO:0003352) | 2.49812171 |
| 80 | cell proliferation in forebrain (GO:0021846) | 2.47379968 |
| 81 | regulation of sarcomere organization (GO:0060297) | 2.46756632 |
| 82 | glycosphingolipid biosynthetic process (GO:0006688) | 2.46669440 |
| 83 | neural tube formation (GO:0001841) | 2.45809416 |
| 84 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.44743455 |
| 85 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.44743455 |
| 86 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.44743455 |
| 87 | positive regulation of action potential (GO:0045760) | 2.44573069 |
| 88 | auditory receptor cell stereocilium organization (GO:0060088) | 2.44558934 |
| 89 | tachykinin receptor signaling pathway (GO:0007217) | 2.44428504 |
| 90 | positive regulation of synapse assembly (GO:0051965) | 2.44106990 |
| 91 | photoreceptor cell development (GO:0042461) | 2.43043467 |
| 92 | head development (GO:0060322) | 2.41367183 |
| 93 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.41004443 |
| 94 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.41004443 |
| 95 | alanine transport (GO:0032328) | 2.40851865 |
| 96 | cilium organization (GO:0044782) | 2.40811358 |
| 97 | negative regulation of mast cell activation (GO:0033004) | 2.39025350 |
| 98 | limb bud formation (GO:0060174) | 2.36870860 |
| 99 | cilium assembly (GO:0042384) | 2.36758591 |
| 100 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.35819898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.74237657 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.61190865 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.27951310 |
| 4 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.15024194 |
| 5 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.14596901 |
| 6 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.88965260 |
| 7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.85142963 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.83651486 |
| 9 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.54503792 |
| 10 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.47909627 |
| 11 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.41749041 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.34608996 |
| 13 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.30678971 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.29753196 |
| 15 | FUS_26573619_Chip-Seq_HEK293_Human | 2.26684203 |
| 16 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.24898877 |
| 17 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.01490214 |
| 18 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.93638868 |
| 19 | P300_19829295_ChIP-Seq_ESCs_Human | 1.93063189 |
| 20 | EWS_26573619_Chip-Seq_HEK293_Human | 1.89739928 |
| 21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.77044278 |
| 22 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.75929013 |
| 23 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.74747809 |
| 24 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.73319280 |
| 25 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.70940486 |
| 26 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.68433753 |
| 27 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.67048316 |
| 28 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.58501013 |
| 29 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.58294315 |
| 30 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.57511305 |
| 31 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.57304051 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.56049068 |
| 33 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.55418359 |
| 34 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.53768563 |
| 35 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.53544009 |
| 36 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.53399002 |
| 37 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.52001759 |
| 38 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.51974333 |
| 39 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.51963651 |
| 40 | AR_25329375_ChIP-Seq_VCAP_Human | 1.46576601 |
| 41 | STAT3_23295773_ChIP-Seq_U87_Human | 1.45555476 |
| 42 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.44483690 |
| 43 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.41889784 |
| 44 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.41889784 |
| 45 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.41504739 |
| 46 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.41195133 |
| 47 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.40892477 |
| 48 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37686345 |
| 49 | TCF4_23295773_ChIP-Seq_U87_Human | 1.36016020 |
| 50 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.35630731 |
| 51 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35576912 |
| 52 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.35093967 |
| 53 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.32271953 |
| 54 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.31973190 |
| 55 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.30968889 |
| 56 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.30257401 |
| 57 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.29880733 |
| 58 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.26220891 |
| 59 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.25783038 |
| 60 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.23108185 |
| 61 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.20975659 |
| 62 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.20634837 |
| 63 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.20225300 |
| 64 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.17742294 |
| 65 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17536738 |
| 66 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.17536738 |
| 67 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15766133 |
| 68 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.13945122 |
| 69 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.12251905 |
| 70 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.11850501 |
| 71 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.11588710 |
| 72 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.11519541 |
| 73 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.10716715 |
| 74 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.08834034 |
| 75 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.08038660 |
| 76 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.07841922 |
| 77 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.07841922 |
| 78 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.07407130 |
| 79 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.07397136 |
| 80 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07090577 |
| 81 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.06277482 |
| 82 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.06158261 |
| 83 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03678774 |
| 84 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.02713141 |
| 85 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.00971836 |
| 86 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.98982493 |
| 87 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.98982493 |
| 88 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98233651 |
| 89 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98173624 |
| 90 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.96550044 |
| 91 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96061514 |
| 92 | JUN_21703547_ChIP-Seq_K562_Human | 0.96048863 |
| 93 | KDM2B_26808549_Chip-Seq_REH_Human | 0.95661414 |
| 94 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94614581 |
| 95 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.94562021 |
| 96 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.94436568 |
| 97 | NCOR_22424771_ChIP-Seq_293T_Human | 0.93663143 |
| 98 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.92889671 |
| 99 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.92557524 |
| 100 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.91979996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002736_abnormal_nociception_after | 3.14627981 |
| 2 | MP0001968_abnormal_touch/_nociception | 3.09703338 |
| 3 | MP0001529_abnormal_vocalization | 2.95572020 |
| 4 | MP0008877_abnormal_DNA_methylation | 2.82344748 |
| 5 | MP0003011_delayed_dark_adaptation | 2.62025016 |
| 6 | MP0001986_abnormal_taste_sensitivity | 2.50138341 |
| 7 | MP0002638_abnormal_pupillary_reflex | 2.46783595 |
| 8 | MP0001188_hyperpigmentation | 2.31744664 |
| 9 | MP0003880_abnormal_central_pattern | 2.30672664 |
| 10 | MP0009046_muscle_twitch | 2.18039023 |
| 11 | MP0009745_abnormal_behavioral_response | 2.16730297 |
| 12 | MP0005551_abnormal_eye_electrophysiolog | 2.11984285 |
| 13 | MP0002102_abnormal_ear_morphology | 2.08696042 |
| 14 | MP0005253_abnormal_eye_physiology | 2.08312098 |
| 15 | MP0006276_abnormal_autonomic_nervous | 2.07847571 |
| 16 | MP0004859_abnormal_synaptic_plasticity | 2.07498126 |
| 17 | MP0002272_abnormal_nervous_system | 2.06833048 |
| 18 | MP0000569_abnormal_digit_pigmentation | 2.06486662 |
| 19 | MP0006072_abnormal_retinal_apoptosis | 2.02561539 |
| 20 | MP0003635_abnormal_synaptic_transmissio | 2.00755982 |
| 21 | MP0001486_abnormal_startle_reflex | 1.98129178 |
| 22 | MP0000778_abnormal_nervous_system | 1.82761484 |
| 23 | MP0004885_abnormal_endolymph | 1.81173606 |
| 24 | MP0006292_abnormal_olfactory_placode | 1.80751557 |
| 25 | MP0003787_abnormal_imprinting | 1.79915290 |
| 26 | MP0002653_abnormal_ependyma_morphology | 1.78580970 |
| 27 | MP0002572_abnormal_emotion/affect_behav | 1.72848613 |
| 28 | MP0002734_abnormal_mechanical_nocicepti | 1.65212944 |
| 29 | MP0002063_abnormal_learning/memory/cond | 1.63738207 |
| 30 | MP0002735_abnormal_chemical_nociception | 1.60262646 |
| 31 | MP0008789_abnormal_olfactory_epithelium | 1.59611531 |
| 32 | MP0005084_abnormal_gallbladder_morpholo | 1.59023675 |
| 33 | MP0004043_abnormal_pH_regulation | 1.58197339 |
| 34 | MP0001984_abnormal_olfaction | 1.57689826 |
| 35 | MP0004270_analgesia | 1.57268483 |
| 36 | MP0002733_abnormal_thermal_nociception | 1.56350060 |
| 37 | MP0002064_seizures | 1.55045860 |
| 38 | MP0004924_abnormal_behavior | 1.52886434 |
| 39 | MP0005386_behavior/neurological_phenoty | 1.52886434 |
| 40 | MP0003122_maternal_imprinting | 1.50220930 |
| 41 | MP0005499_abnormal_olfactory_system | 1.50001460 |
| 42 | MP0005394_taste/olfaction_phenotype | 1.50001460 |
| 43 | MP0001970_abnormal_pain_threshold | 1.48281747 |
| 44 | MP0001501_abnormal_sleep_pattern | 1.45761809 |
| 45 | MP0004142_abnormal_muscle_tone | 1.41382260 |
| 46 | MP0000631_abnormal_neuroendocrine_gland | 1.39815968 |
| 47 | MP0002557_abnormal_social/conspecific_i | 1.39190324 |
| 48 | MP0002067_abnormal_sensory_capabilities | 1.35789806 |
| 49 | MP0002938_white_spotting | 1.31693118 |
| 50 | MP0003195_calcinosis | 1.26627113 |
| 51 | MP0003567_abnormal_fetal_cardiomyocyte | 1.24816784 |
| 52 | MP0005367_renal/urinary_system_phenotyp | 1.21770736 |
| 53 | MP0000516_abnormal_urinary_system | 1.21770736 |
| 54 | MP0000049_abnormal_middle_ear | 1.19848145 |
| 55 | MP0004133_heterotaxia | 1.18838589 |
| 56 | MP0000427_abnormal_hair_cycle | 1.17989000 |
| 57 | MP0002837_dystrophic_cardiac_calcinosis | 1.17348565 |
| 58 | MP0004147_increased_porphyrin_level | 1.15538587 |
| 59 | MP0002752_abnormal_somatic_nervous | 1.14320322 |
| 60 | MP0001905_abnormal_dopamine_level | 1.13917681 |
| 61 | MP0003137_abnormal_impulse_conducting | 1.10852550 |
| 62 | MP0003119_abnormal_digestive_system | 1.09530413 |
| 63 | MP0008872_abnormal_physiological_respon | 1.08858614 |
| 64 | MP0003121_genomic_imprinting | 1.08700781 |
| 65 | MP0002184_abnormal_innervation | 1.08698033 |
| 66 | MP0002882_abnormal_neuron_morphology | 1.05758286 |
| 67 | MP0000955_abnormal_spinal_cord | 1.04664732 |
| 68 | MP0004811_abnormal_neuron_physiology | 1.04203452 |
| 69 | MP0002751_abnormal_autonomic_nervous | 1.03664577 |
| 70 | MP0005646_abnormal_pituitary_gland | 1.03008961 |
| 71 | MP0008058_abnormal_DNA_repair | 1.01647763 |
| 72 | MP0001485_abnormal_pinna_reflex | 1.01375105 |
| 73 | MP0000372_irregular_coat_pigmentation | 0.99843973 |
| 74 | MP0005423_abnormal_somatic_nervous | 0.99644769 |
| 75 | MP0005391_vision/eye_phenotype | 0.98290985 |
| 76 | MP0004742_abnormal_vestibular_system | 0.97586625 |
| 77 | MP0005195_abnormal_posterior_eye | 0.96270127 |
| 78 | MP0003718_maternal_effect | 0.95189603 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 0.94325898 |
| 80 | MP0002069_abnormal_eating/drinking_beha | 0.91702605 |
| 81 | MP0002234_abnormal_pharynx_morphology | 0.91633515 |
| 82 | MP0001963_abnormal_hearing_physiology | 0.91154566 |
| 83 | MP0001502_abnormal_circadian_rhythm | 0.89952303 |
| 84 | MP0000026_abnormal_inner_ear | 0.89791233 |
| 85 | MP0010386_abnormal_urinary_bladder | 0.88892886 |
| 86 | MP0001177_atelectasis | 0.87691164 |
| 87 | MP0002066_abnormal_motor_capabilities/c | 0.87406837 |
| 88 | MP0008875_abnormal_xenobiotic_pharmacok | 0.87348499 |
| 89 | MP0003136_yellow_coat_color | 0.86971862 |
| 90 | MP0003252_abnormal_bile_duct | 0.86198310 |
| 91 | MP0002229_neurodegeneration | 0.85604241 |
| 92 | MP0002152_abnormal_brain_morphology | 0.84125207 |
| 93 | MP0002876_abnormal_thyroid_physiology | 0.83824927 |
| 94 | MP0001440_abnormal_grooming_behavior | 0.82868135 |
| 95 | MP0002233_abnormal_nose_morphology | 0.81254946 |
| 96 | MP0003890_abnormal_embryonic-extraembry | 0.80328076 |
| 97 | MP0005645_abnormal_hypothalamus_physiol | 0.78762816 |
| 98 | MP0004085_abnormal_heartbeat | 0.78227358 |
| 99 | MP0003861_abnormal_nervous_system | 0.77356101 |
| 100 | MP0004215_abnormal_myocardial_fiber | 0.76218662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pendular nystagmus (HP:0012043) | 3.85978496 |
| 2 | Pancreatic fibrosis (HP:0100732) | 3.68375244 |
| 3 | Pancreatic cysts (HP:0001737) | 3.67751495 |
| 4 | Hyperventilation (HP:0002883) | 3.64903685 |
| 5 | Genetic anticipation (HP:0003743) | 3.41527828 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 3.37760082 |
| 7 | True hermaphroditism (HP:0010459) | 3.26946713 |
| 8 | Action tremor (HP:0002345) | 3.23600307 |
| 9 | Medial flaring of the eyebrow (HP:0010747) | 3.21906473 |
| 10 | Abnormality of midbrain morphology (HP:0002418) | 3.14088049 |
| 11 | Molar tooth sign on MRI (HP:0002419) | 3.14088049 |
| 12 | Gait imbalance (HP:0002141) | 3.01588476 |
| 13 | Focal seizures (HP:0007359) | 3.00994113 |
| 14 | Focal motor seizures (HP:0011153) | 2.97367176 |
| 15 | Dialeptic seizures (HP:0011146) | 2.89334513 |
| 16 | Absent speech (HP:0001344) | 2.85279462 |
| 17 | Gaze-evoked nystagmus (HP:0000640) | 2.76880855 |
| 18 | Nephronophthisis (HP:0000090) | 2.75792081 |
| 19 | Hyperglycinemia (HP:0002154) | 2.74730489 |
| 20 | Drooling (HP:0002307) | 2.74192542 |
| 21 | Abnormality of the labia minora (HP:0012880) | 2.72132907 |
| 22 | Lissencephaly (HP:0001339) | 2.71123664 |
| 23 | Congenital primary aphakia (HP:0007707) | 2.68741133 |
| 24 | Hypsarrhythmia (HP:0002521) | 2.66097783 |
| 25 | Abolished electroretinogram (ERG) (HP:0000550) | 2.63170473 |
| 26 | Inability to walk (HP:0002540) | 2.56592687 |
| 27 | Congenital stationary night blindness (HP:0007642) | 2.55310389 |
| 28 | EEG with generalized epileptiform discharges (HP:0011198) | 2.53524738 |
| 29 | Broad-based gait (HP:0002136) | 2.52170035 |
| 30 | Febrile seizures (HP:0002373) | 2.51288603 |
| 31 | Type II lissencephaly (HP:0007260) | 2.51128340 |
| 32 | Absence seizures (HP:0002121) | 2.50337314 |
| 33 | Excessive salivation (HP:0003781) | 2.47159569 |
| 34 | Limb dystonia (HP:0002451) | 2.46772316 |
| 35 | Epileptiform EEG discharges (HP:0011182) | 2.43958253 |
| 36 | Nephrogenic diabetes insipidus (HP:0009806) | 2.43929290 |
| 37 | Tubulointerstitial nephritis (HP:0001970) | 2.39250460 |
| 38 | Abnormality of the renal medulla (HP:0100957) | 2.38352068 |
| 39 | Polyphagia (HP:0002591) | 2.37412067 |
| 40 | Genital tract atresia (HP:0001827) | 2.35001943 |
| 41 | Abnormality of the renal cortex (HP:0011035) | 2.33197198 |
| 42 | Epileptic encephalopathy (HP:0200134) | 2.28763016 |
| 43 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.27022947 |
| 44 | Pachygyria (HP:0001302) | 2.25724353 |
| 45 | Increased corneal curvature (HP:0100692) | 2.25290512 |
| 46 | Keratoconus (HP:0000563) | 2.25290512 |
| 47 | Vaginal atresia (HP:0000148) | 2.24936891 |
| 48 | Cystic liver disease (HP:0006706) | 2.22791111 |
| 49 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.22773411 |
| 50 | Absent/shortened dynein arms (HP:0200106) | 2.22773411 |
| 51 | Hyperglycinuria (HP:0003108) | 2.18808143 |
| 52 | Hemiparesis (HP:0001269) | 2.17831124 |
| 53 | Retinal dysplasia (HP:0007973) | 2.17652723 |
| 54 | Methylmalonic acidemia (HP:0002912) | 2.15818252 |
| 55 | Narrow forehead (HP:0000341) | 2.12345939 |
| 56 | Postaxial foot polydactyly (HP:0001830) | 2.10198117 |
| 57 | Chronic hepatic failure (HP:0100626) | 2.08218765 |
| 58 | Chorioretinal atrophy (HP:0000533) | 2.07497717 |
| 59 | Postaxial hand polydactyly (HP:0001162) | 2.06952890 |
| 60 | Tubular atrophy (HP:0000092) | 2.05886760 |
| 61 | Atonic seizures (HP:0010819) | 2.03724213 |
| 62 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.03101922 |
| 63 | Sclerocornea (HP:0000647) | 2.02149378 |
| 64 | Spastic tetraplegia (HP:0002510) | 2.01981615 |
| 65 | Short tibia (HP:0005736) | 2.01878150 |
| 66 | Protruding tongue (HP:0010808) | 2.01690629 |
| 67 | Progressive inability to walk (HP:0002505) | 2.00680559 |
| 68 | Dysdiadochokinesis (HP:0002075) | 2.00191479 |
| 69 | Cerebellar dysplasia (HP:0007033) | 1.99638881 |
| 70 | Abnormality of glycine metabolism (HP:0010895) | 1.98779701 |
| 71 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.98779701 |
| 72 | Abnormal drinking behavior (HP:0030082) | 1.98681380 |
| 73 | Polydipsia (HP:0001959) | 1.98681380 |
| 74 | Cortical dysplasia (HP:0002539) | 1.98017514 |
| 75 | Abnormality of macular pigmentation (HP:0008002) | 1.96948050 |
| 76 | Specific learning disability (HP:0001328) | 1.95453219 |
| 77 | Generalized myoclonic seizures (HP:0002123) | 1.92721531 |
| 78 | Congenital hepatic fibrosis (HP:0002612) | 1.91938207 |
| 79 | Anencephaly (HP:0002323) | 1.89598056 |
| 80 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.88390857 |
| 81 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.88390857 |
| 82 | Oculomotor apraxia (HP:0000657) | 1.87049810 |
| 83 | Supernumerary spleens (HP:0009799) | 1.86274605 |
| 84 | Male pseudohermaphroditism (HP:0000037) | 1.86236953 |
| 85 | Myokymia (HP:0002411) | 1.86056698 |
| 86 | Optic nerve hypoplasia (HP:0000609) | 1.85673681 |
| 87 | Retinitis pigmentosa (HP:0000510) | 1.84704887 |
| 88 | Attenuation of retinal blood vessels (HP:0007843) | 1.84626073 |
| 89 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.83824886 |
| 90 | Polymicrogyria (HP:0002126) | 1.82071489 |
| 91 | Abnormal ciliary motility (HP:0012262) | 1.82024574 |
| 92 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.81519785 |
| 93 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.80693291 |
| 94 | Renal cortical cysts (HP:0000803) | 1.80668149 |
| 95 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.78933284 |
| 96 | Short foot (HP:0001773) | 1.78125570 |
| 97 | Acute encephalopathy (HP:0006846) | 1.77869502 |
| 98 | Poor eye contact (HP:0000817) | 1.76487927 |
| 99 | Muscular hypotonia of the trunk (HP:0008936) | 1.75785685 |
| 100 | Poor coordination (HP:0002370) | 1.75754933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.90713103 |
| 2 | WNK3 | 3.80684274 |
| 3 | MARK1 | 3.56167332 |
| 4 | MAPK13 | 3.24141719 |
| 5 | CDK19 | 3.19136323 |
| 6 | CASK | 2.95441201 |
| 7 | MAP3K4 | 2.88413251 |
| 8 | GRK1 | 2.59429213 |
| 9 | MAP2K7 | 2.38975846 |
| 10 | MAP4K2 | 2.38268089 |
| 11 | BMPR1B | 2.18841838 |
| 12 | TRIM28 | 2.07140490 |
| 13 | PINK1 | 2.06681450 |
| 14 | ADRBK2 | 2.01631476 |
| 15 | NUAK1 | 1.94885453 |
| 16 | OXSR1 | 1.94582096 |
| 17 | TNIK | 1.92711611 |
| 18 | AKT3 | 1.87392219 |
| 19 | DYRK2 | 1.83920613 |
| 20 | BCR | 1.60747394 |
| 21 | PNCK | 1.52523788 |
| 22 | NTRK2 | 1.47462298 |
| 23 | PRKCG | 1.35483350 |
| 24 | CSNK1G2 | 1.35040331 |
| 25 | TIE1 | 1.34995201 |
| 26 | MKNK2 | 1.32993659 |
| 27 | STK16 | 1.32811174 |
| 28 | INSRR | 1.31159939 |
| 29 | CSNK1G3 | 1.29172462 |
| 30 | CSNK1A1L | 1.27506050 |
| 31 | PRKCE | 1.24212912 |
| 32 | CSNK1G1 | 1.23732795 |
| 33 | ZAK | 1.16293636 |
| 34 | PLK2 | 1.15660749 |
| 35 | BCKDK | 1.15033324 |
| 36 | PRKD3 | 1.14928483 |
| 37 | MAP2K4 | 1.09589082 |
| 38 | PKN1 | 1.09581957 |
| 39 | PAK3 | 1.08132525 |
| 40 | CCNB1 | 1.06732003 |
| 41 | DAPK2 | 1.02817296 |
| 42 | ERBB3 | 0.96635075 |
| 43 | MKNK1 | 0.84938701 |
| 44 | SGK223 | 0.80787353 |
| 45 | SGK494 | 0.80787353 |
| 46 | SGK2 | 0.80407010 |
| 47 | DYRK1A | 0.78353244 |
| 48 | EPHA4 | 0.78136353 |
| 49 | WNK4 | 0.77996583 |
| 50 | PHKG2 | 0.77422558 |
| 51 | PHKG1 | 0.77422558 |
| 52 | STK38L | 0.74046929 |
| 53 | TLK1 | 0.72701282 |
| 54 | DYRK3 | 0.68107961 |
| 55 | SRPK1 | 0.65378225 |
| 56 | NTRK3 | 0.64098988 |
| 57 | CAMK2A | 0.61836064 |
| 58 | TXK | 0.58541696 |
| 59 | VRK1 | 0.57675295 |
| 60 | FGFR2 | 0.57643634 |
| 61 | PLK3 | 0.56961428 |
| 62 | PRKCZ | 0.56532379 |
| 63 | UHMK1 | 0.54686545 |
| 64 | PTK2B | 0.54446375 |
| 65 | CDK5 | 0.50959004 |
| 66 | PRKACA | 0.49956778 |
| 67 | CSNK1D | 0.48299490 |
| 68 | ADRBK1 | 0.47524193 |
| 69 | CSNK1A1 | 0.47083107 |
| 70 | FER | 0.46807081 |
| 71 | EPHA3 | 0.46636021 |
| 72 | CAMK2B | 0.46441811 |
| 73 | LIMK1 | 0.46170853 |
| 74 | TGFBR1 | 0.45304004 |
| 75 | TAOK3 | 0.43261997 |
| 76 | PRKAA1 | 0.41429706 |
| 77 | MAP3K6 | 0.40059148 |
| 78 | RPS6KA4 | 0.39922913 |
| 79 | TSSK6 | 0.39873264 |
| 80 | PRKG1 | 0.39729722 |
| 81 | STK38 | 0.39486566 |
| 82 | TNK2 | 0.38063529 |
| 83 | CAMK2D | 0.37085038 |
| 84 | WEE1 | 0.36897537 |
| 85 | MINK1 | 0.36570291 |
| 86 | GRK5 | 0.36569784 |
| 87 | CAMK4 | 0.36389083 |
| 88 | ACVR1B | 0.36297150 |
| 89 | MAP3K9 | 0.36286293 |
| 90 | DAPK1 | 0.36054611 |
| 91 | CAMKK2 | 0.34952137 |
| 92 | CDK9 | 0.34662174 |
| 93 | CSNK1E | 0.34185531 |
| 94 | PLK4 | 0.34085577 |
| 95 | STK11 | 0.31415589 |
| 96 | PAK6 | 0.29624881 |
| 97 | TAF1 | 0.28284248 |
| 98 | PRKCB | 0.27593802 |
| 99 | PRKCA | 0.26711815 |
| 100 | EPHB2 | 0.26514002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.20490198 |
| 2 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.15445666 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.95038741 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 2.57771910 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.37359994 |
| 6 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.33784763 |
| 7 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.19806921 |
| 8 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.15660613 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.15449902 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.11091057 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.96415991 |
| 12 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.88306432 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.81440400 |
| 14 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.80849676 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 1.74809630 |
| 16 | GABAergic synapse_Homo sapiens_hsa04727 | 1.74734067 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 1.70481365 |
| 18 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.68739397 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.65015716 |
| 20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.62118850 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60722302 |
| 22 | Protein export_Homo sapiens_hsa03060 | 1.57213574 |
| 23 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.57029976 |
| 24 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.56915838 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.53075820 |
| 26 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.52128073 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.50090148 |
| 28 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.47319806 |
| 29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.46041630 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.40514731 |
| 31 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.37562946 |
| 32 | Basal transcription factors_Homo sapiens_hsa03022 | 1.34996786 |
| 33 | Olfactory transduction_Homo sapiens_hsa04740 | 1.32392025 |
| 34 | Circadian entrainment_Homo sapiens_hsa04713 | 1.31580886 |
| 35 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.20259998 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.19407284 |
| 37 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.18662257 |
| 38 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.16916682 |
| 39 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.16281120 |
| 40 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.15752121 |
| 41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.14195730 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.13021091 |
| 43 | Homologous recombination_Homo sapiens_hsa03440 | 1.11404247 |
| 44 | Parkinsons disease_Homo sapiens_hsa05012 | 1.10152437 |
| 45 | Long-term depression_Homo sapiens_hsa04730 | 1.09115909 |
| 46 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.08573352 |
| 47 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.01816883 |
| 48 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.01132273 |
| 49 | Insulin secretion_Homo sapiens_hsa04911 | 0.99698421 |
| 50 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.97127223 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96812201 |
| 52 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.92550911 |
| 53 | Peroxisome_Homo sapiens_hsa04146 | 0.92508460 |
| 54 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.86227196 |
| 55 | RNA degradation_Homo sapiens_hsa03018 | 0.83449718 |
| 56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.82115942 |
| 57 | Cocaine addiction_Homo sapiens_hsa05030 | 0.81840050 |
| 58 | Axon guidance_Homo sapiens_hsa04360 | 0.81184050 |
| 59 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.78874348 |
| 60 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.75944449 |
| 61 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.73582047 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73500880 |
| 63 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.73311734 |
| 64 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.72706968 |
| 65 | Circadian rhythm_Homo sapiens_hsa04710 | 0.72480848 |
| 66 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.71138507 |
| 67 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.70844280 |
| 68 | Huntingtons disease_Homo sapiens_hsa05016 | 0.68582031 |
| 69 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.67354820 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65378022 |
| 71 | Histidine metabolism_Homo sapiens_hsa00340 | 0.64187509 |
| 72 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62857824 |
| 73 | Purine metabolism_Homo sapiens_hsa00230 | 0.62590095 |
| 74 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.61351167 |
| 75 | Salivary secretion_Homo sapiens_hsa04970 | 0.60558751 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.58516037 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57965182 |
| 78 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.55803636 |
| 79 | Alzheimers disease_Homo sapiens_hsa05010 | 0.54149940 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.53625753 |
| 81 | ABC transporters_Homo sapiens_hsa02010 | 0.53257426 |
| 82 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53112783 |
| 83 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.52899573 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51509958 |
| 85 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.45862860 |
| 86 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45089133 |
| 87 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.44497040 |
| 88 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.43191025 |
| 89 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.42478269 |
| 90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42389173 |
| 91 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.42172928 |
| 92 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.40493497 |
| 93 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.40201352 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39700548 |
| 95 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.39462659 |
| 96 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38922494 |
| 97 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38499462 |
| 98 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.34442113 |
| 99 | Lysine degradation_Homo sapiens_hsa00310 | 0.34177762 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34072667 |

